OCUL

Ocular Therapeutix Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 2/10
  • Value↓ 0/10
Ocular Therapeutix sales and earnings growth
OCUL Growth
Fair
  • Revenue Y/Y↓ -12.76%
  • EPS Y/Y↓ -26.32%
  • FCF Y/Y↓ -62.24%
Ocular Therapeutix gross and profit margin trends
OCUL Profitability
Low
  • Gross margin ↑ 87.20%
  • EPS margin↓ -558.20%
  • ROIC 5Y↓ -168.82%
Ocular Therapeutix net debt vs free cash flow
OCUL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -24.0

Ocular Therapeutix stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks